---
layout: post
title: "莱美药业：注射用甲泼尼龙琥珀酸钠通过仿制药一致性评价"
date: 2022-02-22 17:30:51 +0800
categories: cailianshe
tags: 财联社新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.300006" data-code="300006|0|2" data-code2="300006|0|80|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.300006&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 300006_0" data-code="K 300006|0|2" data-code2="K 300006|0|80|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>莱美药业公告，公司药品注射用甲泼尼龙琥珀酸钠(规格：40mg)通过仿制药一致性评价。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202222284860931>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)